Checked out SLXP from what I can gather they area generic drug company. Salix SLXP is a well established company that has 23 drugs all or most are generic (please jump all over this if incorrect). Net income -$475 million net. Shares fully diluted 75 million. Share price $119.10 And we are coming out of the gate with over 30 generic drugs. Its not hard to see what dart is excited about. From their Mission statement- Identifying and acquiring rights to products with the potential for near-term regulatory approval or that are already approved. https://cdn.salix.com/salix/assets/pdf/salix-pharmaceuticals-corporate-presentation.pdf